ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong
· Delayed Price · Currency is HKD 5.02
+0.22 (4.58%)
Mar 10, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 2.07 billion as of March 10, 2026. Its market cap has decreased by -12.48% in one year.
Market Cap
2.07B
Enterprise Value
1.47B
Revenue
134.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.02
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 2.07B, a decrease of -71.57%. That is a compound annual growth rate of -39.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.07B | -17.67% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.85B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.98B |
| Cutia Therapeutics | 1.71B |
| Mabpharm | 1.69B |
| Frontage Holdings | 2.23B |
| Clover Biopharmaceuticals | 2.51B |
| Immunotech Biopharm | 1.45B |
| Kintor Pharmaceutical | 1.44B |